Literature DB >> 17002671

Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats.

Sameer Sharma1, Shrinivas K Kulkarni, Kanwaljit Chopra.   

Abstract

Chronic hyperglycaemia in diabetes leads to the overproduction of free radicals and evidence is increasing that these contribute to the development of diabetic nephropathy. Among the spices, turmeric (Curcuma longa) is used as a flavouring and colouring agent in the indian diet every day and is known to possess anti-oxidant properties. The present study was designed to examine the effect of curcumin, a yellow pigment of turmeric, on renal function and oxidative stress in streptozotocin (STZ)-induced diabetic rats. Diabetes was induced by a single intraperitoneal injection of STZ (65 mg/kg) in rats. Four weeks after STZ injection, rats were divided into four groups, namely control rats, diabetic rats and diabetic rats treated with curcumin (15 and 30 mg/kg, p.o.) for 2 weeks. Renal function was assessed by creatinine, blood urea nitrogen, creatinine and urea clearance and urine albumin excretion. Oxidative stress was measured by renal malonaldehyde, reduced glutathione and the anti-oxidant enzymes superoxide dismutase and catalase. Streptozotocin-injected rats showed significant increases in blood glucose, polyuria and a decrease in bodyweight compared with age-matched control rats. After 6 weeks, diabetic rats also exhibited renal dysfunction, as evidenced by reduced creatinine and urea clearance and proteinuria, along with a marked increase in oxidative stress, as determined by lipid peroxidation and activities of key anti-oxidant enzymes. Chronic treatment with curcumin significantly attenuated both renal dysfunction and oxidative stress in diabetic rats. These results provide confirmatory evidence of oxidative stress in diabetic nephropathy and point towards the possible anti-oxidative mechanism being responsible for the nephroprotective action of curcumin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17002671     DOI: 10.1111/j.1440-1681.2006.04468.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  72 in total

1.  Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2.

Authors:  Jianguo Lin; Anping Chen
Journal:  Mol Cell Endocrinol       Date:  2010-12-30       Impact factor: 4.102

2.  Oxidative stress parameters in blood, liver, and kidney of diabetic rats treated with curcumin and/or insulin.

Authors:  Heloisa Einloft Palma; Patrícia Wolkmer; Miguel Gallio; Marcos M B Corrêa; Roberta Schmatz; Gustavo R Thomé; Luciane B Pereira; Verônica S P Castro; Andréia B Pereira; Andressa Bueno; Lizielle S de Oliveira; Debora Rosolen; Thaís R Mann; Bianca S de Cecco; Dominguita L Graça; Sonia T A Lopes; Cinthia M A Mazzanti
Journal:  Mol Cell Biochem       Date:  2013-10-16       Impact factor: 3.396

Review 3.  Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases.

Authors:  Amir Abbas Momtazi; Giuseppe Derosa; Pamela Maffioli; Maciej Banach; Amirhossein Sahebkar
Journal:  Mol Diagn Ther       Date:  2016-08       Impact factor: 4.074

Review 4.  Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.

Authors:  Bharat B Aggarwal; Kuzhuvelil B Harikumar
Journal:  Int J Biochem Cell Biol       Date:  2008-07-09       Impact factor: 5.085

Review 5.  Therapeutic approaches to diabetic nephropathy--beyond the RAS.

Authors:  Beatriz Fernandez-Fernandez; Alberto Ortiz; Carmen Gomez-Guerrero; Jesus Egido
Journal:  Nat Rev Nephrol       Date:  2014-05-06       Impact factor: 28.314

6.  Change in post-translational modifications of histone H3, heat-shock protein-27 and MAP kinase p38 expression by curcumin in streptozotocin-induced type I diabetic nephropathy.

Authors:  K Tikoo; R L Meena; D G Kabra; A B Gaikwad
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

7.  Effect of sesamol on diabetes-associated cognitive decline in rats.

Authors:  Anurag Kuhad; Kanwaljit Chopra
Journal:  Exp Brain Res       Date:  2007-10-23       Impact factor: 1.972

8.  Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress.

Authors:  Jianguo Lin; Shizhong Zheng; Anping Chen
Journal:  Lab Invest       Date:  2009-10-19       Impact factor: 5.662

9.  Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC.

Authors:  Jun Ma; Lynetta Phillips; Ying Wang; Tiane Dai; Janine LaPage; Rama Natarajan; Sharon G Adler
Journal:  BMC Complement Altern Med       Date:  2010-11-12       Impact factor: 3.659

10.  Effects of Curcuma longa (turmeric) on postprandial plasma glucose and insulin in healthy subjects.

Authors:  Jennie Wickenberg; Sandra Lindstedt Ingemansson; Joanna Hlebowicz
Journal:  Nutr J       Date:  2010-10-12       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.